FindTrial
Sign In

A research study to evaluate the effectiveness of panchanimbakam churna tablet and pathyadi lepa(Ayurvedic ointment) in psoriasis disease

AN OPEN LABEL SINGLE ARM CLINICAL STUDY ON COMBINED THE COMBINED EFFECTIVENESS OF PANCHANIMBAKAM CHURNA VATI AND PATHYADI LEPA IN KITIBA KUSHTA (PSORIASIS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031318
Enrollment
30
Registered
2021-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: L409- Psoriasis, unspecified

Interventions

Intervention1: Panchanimbakam Churna vati : 500mg (2 tablets) thrice daily, after food for a period of 30days. Intervention2: Pathyadi lepa: external application will be mixed with water and applied

Sponsors

SDM College of Ayurveda Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering with Kitibha Kushta 2. Patients of either gender, aged between 18-60 years. [10] 3. Patient willing to participate in the study and ready to sign informed consent form

Exclusion criteria

Exclusion criteria: Patients with systemic illness such as impaired cardiac, renal and hepatic functions. 2. Metabolic disorders namely diabetes mellitus type 2 and essential hypertension. 3. Pregnant women and lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in the PASI scale and symptoms of Kitibha KushtaTimepoint: outcomes will be assessed at baseline, 15 days and 30 days—

Secondary

MeasureTime frame
PASI scaleTimepoint: 15 days and 30 days—

Countries

India

Contacts

Public ContactDr Kalpana

SDM College of Ayurveda Hassan

sooryajadhav@gmail.com9886614116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026